PEGCETACOPLAN

PEGCETACOPLAN was reported 1899 times

These side effects are most commonly reported by patients taking PEGCETACOPLAN:

# Side effect Count
0 FATIGUE 169
1 OFF LABEL USE 155
2 VISUAL IMPAIRMENT 145
3 HAEMOGLOBIN DECREASED 129
4 VITREOUS FLOATERS 116
5 HAEMOLYSIS 109
6 BREAKTHROUGH HAEMOLYSIS 96
7 HEADACHE 92
8 UVEITIS 80
9 PRODUCT DOSE OMISSION ISSUE 75
10 VITRITIS 75
11 DRUG INEFFECTIVE 73
12 EYE INFLAMMATION 72
13 VISION BLURRED 67
14 DEATH 66
15 NEOVASCULAR AGE-RELATED MACULAR DEGENERATION 66
16 CHOROIDAL NEOVASCULARISATION 65
17 PYREXIA 65
18 CONDITION AGGRAVATED 64
19 COVID-19 62
20 DIARRHOEA 61
21 RETINAL HAEMORRHAGE 61
22 INJECTION SITE PAIN 60
23 MALAISE 57
24 INTRAOCULAR PRESSURE INCREASED 56
25 NAUSEA 56
26 BLINDNESS 55
27 PLATELET COUNT DECREASED 54
28 DIZZINESS 52
29 RETINAL VASCULITIS 52
30 EYE PAIN 51
31 BLOOD LACTATE DEHYDROGENASE INCREASED 44
32 PRURITUS 44
33 ASTHENIA 43
34 ENDOPHTHALMITIS 43
35 PNEUMONIA 43
36 INFECTION 41
37 ANAEMIA 40
38 ARTHRALGIA 40
39 PAIN 40
40 ACUTE KIDNEY INJURY 39
41 VOMITING 39
42 ABDOMINAL PAIN 38
43 INJECTION SITE SWELLING 38
44 DYSPNOEA 35
45 IRITIS 35
46 RENAL IMPAIRMENT 35
47 NASOPHARYNGITIS 34
48 VISUAL ACUITY REDUCED 34
49 OCULAR HYPERAEMIA 33
50 BACK PAIN 32
51 CHROMATURIA 32
52 VITREOUS DETACHMENT 32
53 IRIDOCYCLITIS 31
54 RETINAL OCCLUSIVE VASCULITIS 31
55 INFLUENZA 30
56 COUGH 29
57 EYE COMPLICATION ASSOCIATED WITH DEVICE 29
58 THROMBOCYTOPENIA 29
59 DISEASE PROGRESSION 27
60 DRY AGE-RELATED MACULAR DEGENERATION 27
61 RASH 27
62 DECREASED APPETITE 26
63 FALL 26
64 INJECTION SITE PRURITUS 26
65 URINARY TRACT INFECTION 26
66 INTRA-OCULAR INJECTION COMPLICATION 25
67 ANTERIOR CHAMBER CELL 24
68 INCORRECT DOSE ADMINISTERED 24
69 INJECTION SITE ERYTHEMA 24
70 CORNEAL OEDEMA 23
71 PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA 22
72 SEPSIS 22
73 INFUSION SITE PAIN 21
74 OCULAR HYPERTENSION 21
75 DRY EYE 20
76 HYPERTENSION 20
77 CONTUSION 19
78 EYE HAEMORRHAGE 19
79 INJECTION SITE HAEMORRHAGE 19
80 PHOTOPHOBIA 19
81 ABDOMINAL PAIN UPPER 18
82 ERYTHEMA 18
83 HYPERSENSITIVITY 18
84 INCORRECT PRODUCT ADMINISTRATION DURATION 18
85 PAIN IN EXTREMITY 18
86 SEPTIC SHOCK 18
87 VIRAL INFECTION 18
88 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 18
89 BLINDNESS TRANSIENT 17
90 BLOOD CREATININE INCREASED 17
91 CHEST PAIN 17
92 CHILLS 17
93 HAEMOGLOBIN ABNORMAL 17
94 INFUSION SITE SWELLING 17
95 INTENTIONAL DOSE OMISSION 17
96 OCULAR DISCOMFORT 17
97 OPTIC ISCHAEMIC NEUROPATHY 17
98 ANXIETY 16
99 BONE MARROW FAILURE 16
100 HAEMORRHAGIC OCCLUSIVE RETINAL VASCULITIS 16
101 VITREOUS HAEMORRHAGE 16
102 VITREOUS OPACITIES 16
103 APLASTIC ANAEMIA 15
104 BLOOD URINE PRESENT 15
105 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 15
106 PERIPHERAL SWELLING 15
107 VITREAL CELLS 15
108 ABDOMINAL DISTENSION 14
109 BLOOD PRESSURE INCREASED 14
110 CONJUNCTIVAL HAEMORRHAGE 14
111 HAEMATURIA 14
112 INJECTION SITE INDURATION 14
113 MIGRAINE 14
114 OEDEMA 14
115 SOMNOLENCE 14
116 BACTERIAL ENDOPHTHALMITIS 13
117 BRAIN FOG 13
118 CATARACT 13
119 CONFUSIONAL STATE 13
120 EXTRAVASCULAR HAEMOLYSIS 13
121 EYE IRRITATION 13
122 GLAUCOMA 13
123 MYELODYSPLASTIC SYNDROME 13
124 NEEDLE ISSUE 13
125 PHOTOPSIA 13
126 RHINORRHOEA 13
127 URTICARIA 13
128 WHITE BLOOD CELL COUNT DECREASED 13
129 ABDOMINAL DISCOMFORT 12
130 DYSPHONIA 12
131 EPISTAXIS 12
132 INSOMNIA 12
133 PAPILLOEDEMA 12
134 PULMONARY EMBOLISM 12
135 ANTERIOR CHAMBER INFLAMMATION 11
136 CYTOPENIA 11
137 ILLNESS 11
138 INFUSION SITE PRURITUS 11
139 JAUNDICE 11
140 PRODUCT TEMPERATURE EXCURSION ISSUE 11
141 RETINAL ISCHAEMIA 11
142 STAPHYLOCOCCAL INFECTION 11
143 WEIGHT INCREASED 11
144 DEHYDRATION 10
145 EYE INFECTION 10
146 HAEMORRHAGE 10
147 HYPHAEMA 10
148 INJECTION SITE BRUISING 10
149 IRIS NEOVASCULARISATION 10
150 LABORATORY TEST ABNORMAL 10
151 MACULAR OEDEMA 10
152 MULTIPLE ORGAN DYSFUNCTION SYNDROME 10
153 NEUTROPENIA 10
154 OEDEMA PERIPHERAL 10
155 PROTEINURIA 10
156 RENAL FAILURE 10
157 RETINAL VEIN OCCLUSION 10
158 THROMBOSIS 10
159 VISUAL FIELD DEFECT 10
160 WEIGHT DECREASED 10
161 ADVERSE DRUG REACTION 9
162 BACTERAEMIA 9
163 BLINDNESS UNILATERAL 9
164 C3 GLOMERULOPATHY 9
165 CONJUNCTIVAL OEDEMA 9
166 EPIRETINAL MEMBRANE 9
167 ESCHERICHIA INFECTION 9
168 HAEMOGLOBINURIA 9
169 HERPES ZOSTER 9
170 INFUSION SITE BRUISING 9
171 INJECTION SITE DISCOMFORT 9
172 MEMORY IMPAIRMENT 9
173 METAMORPHOPSIA 9
174 MUSCULAR WEAKNESS 9
175 OPTIC DISC OEDEMA 9
176 PALPITATIONS 9
177 RETICULOCYTE COUNT INCREASED 9
178 TREATMENT NONCOMPLIANCE 9
179 ANTERIOR SEGMENT NEOVASCULARISATION 8
180 BLOOD BILIRUBIN INCREASED 8
181 CAMPYLOBACTER INFECTION 8
182 CELLULITIS 8
183 CROHN^S DISEASE 8
184 DEVICE ISSUE 8
185 DEVICE LEAKAGE 8
186 DYSSTASIA 8
187 EAR DISCOMFORT 8
188 FEELING ABNORMAL 8
189 GAIT DISTURBANCE 8
190 GENE MUTATION 8
191 GENERAL PHYSICAL HEALTH DETERIORATION 8
192 HYPOAESTHESIA 8
193 MACULAR DEGENERATION 8
194 MATERNAL EXPOSURE DURING PREGNANCY 8
195 PALLOR 8
196 PHYSICAL DECONDITIONING 8
197 PSEUDOPHAKIA 8
198 RETINAL DETACHMENT 8
199 SPLENIC EMBOLISM 8
200 SWELLING 8
201 THERAPY NON-RESPONDER 8
202 TREMOR 8
203 UTERINE LEIOMYOMA 8
204 ALOPECIA 7
205 ANAPHYLACTIC SHOCK 7
206 ARTHRITIS 7
207 ATRIAL FIBRILLATION 7
208 BLOOD LACTATE DEHYDROGENASE ABNORMAL 7
209 CENTRAL VISION LOSS 7
210 CONSTIPATION 7
211 DYSPHAGIA 7
212 FLANK PAIN 7
213 HEAD INJURY 7
214 HEPATIC CIRRHOSIS 7
215 HYPOPYON 7
216 IMPAIRED DRIVING ABILITY 7
217 INFLAMMATION 7
218 INFUSION SITE ERYTHEMA 7
219 LOSS OF CONSCIOUSNESS 7
220 MYALGIA 7
221 NON-INFECTIOUS ENDOPHTHALMITIS 7
222 OROPHARYNGEAL DISCOMFORT 7
223 OROPHARYNGEAL PAIN 7
224 PARAESTHESIA 7
225 PRODUCT STORAGE ERROR 7
226 RESPIRATORY TRACT INFECTION VIRAL 7
227 SARS-COV-2 TEST POSITIVE 7
228 SCIATICA 7
229 SINUSITIS 7
230 SKIN DISCOLOURATION 7
231 SWELLING FACE 7
232 SWELLING OF EYELID 7
233 SYNCOPE 7
234 ANAPHYLACTIC REACTION 6
235 BLOOD TEST ABNORMAL 6
236 CEREBRAL HAEMORRHAGE 6
237 CEREBROVASCULAR ACCIDENT 6
238 CHORIORETINITIS 6
239 CLOSTRIDIUM DIFFICILE INFECTION 6
240 CONJUNCTIVITIS 6
241 CORNEAL ABRASION 6
242 DEAFNESS 6
243 DEPRESSION 6
244 DEVICE DELIVERY SYSTEM ISSUE 6
245 DISCOMFORT 6
246 END STAGE RENAL DISEASE 6
247 EYE NAEVUS 6
248 EYE SWELLING 6
249 FULL BLOOD COUNT ABNORMAL 6
250 GASTROOESOPHAGEAL REFLUX DISEASE 6
251 HEAVY MENSTRUAL BLEEDING 6
252 HYPOTENSION 6
253 HYPOTONY OF EYE 6
254 INCORRECT DOSE ADMINISTERED BY DEVICE 6
255 INFUSION SITE DISCOLOURATION 6
256 INJECTION SITE MASS 6
257 INTENTIONAL PRODUCT USE ISSUE 6
258 LACRIMATION INCREASED 6
259 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 6
260 LOWER RESPIRATORY TRACT INFECTION 6
261 OPTIC NEURITIS 6
262 PRODUCTIVE COUGH 6
263 RASH PRURITIC 6
264 RED BLOOD CELL COUNT DECREASED 6
265 RENAL TUBULAR DISORDER 6
266 RETINAL TEAR 6
267 RETINAL VASCULAR DISORDER 6
268 SUBRETINAL FLUID 6
269 TACHYCARDIA 6
270 THROMBOTIC MICROANGIOPATHY 6
271 ACUTE MYELOID LEUKAEMIA 5
272 BLOOD IRON DECREASED 5
273 BLOOD POTASSIUM INCREASED 5
274 BODY TEMPERATURE INCREASED 5
275 CARDIAC FAILURE 5
276 CARDIO-RESPIRATORY ARREST 5
277 CATARACT NUCLEAR 5
278 CHEST DISCOMFORT 5
279 CHOROIDITIS 5
280 CHRONIC KIDNEY DISEASE 5
281 COLD SWEAT 5
282 DEVICE USE ERROR 5
283 DIZZINESS POSTURAL 5
284 DRUG EFFECT LESS THAN EXPECTED 5
285 DRUG HYPERSENSITIVITY 5
286 DRY SKIN 5
287 ENTERITIS 5
288 EXTRA DOSE ADMINISTERED 5
289 EYELID OEDEMA 5
290 FLUORESCENCE ANGIOGRAM ABNORMAL 5
291 FOREIGN BODY SENSATION IN EYES 5
292 GASTROENTERITIS VIRAL 5
293 HAPTOGLOBIN DECREASED 5
294 HEART RATE INCREASED 5
295 HEPATIC ENZYME INCREASED 5
296 HEPATIC STEATOSIS 5
297 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 5
298 INFUSION SITE MASS 5
299 INJECTION SITE EXTRAVASATION 5
300 INJECTION SITE REACTION 5
301 INTRAVASCULAR HAEMOLYSIS 5
302 MENTAL IMPAIRMENT 5
303 MOBILITY DECREASED 5
304 MUSCULOSKELETAL STIFFNESS 5
305 NECK PAIN 5
306 OESOPHAGEAL SPASM 5
307 PANCYTOPENIA 5
308 PETECHIAE 5
309 POLLAKIURIA 5
310 POST PROCEDURAL COMPLICATION 5
311 PRODUCT ADMINISTRATION ERROR 5
312 PRODUCT AVAILABILITY ISSUE 5
313 PRODUCT DOSE OMISSION IN ERROR 5
314 PRODUCT LEAKAGE 5
315 PRODUCT USE ISSUE 5
316 RETINAL ARTERY OCCLUSION 5
317 RETINAL OEDEMA 5
318 SPLENOMEGALY 5
319 STAPHYLOCOCCUS TEST POSITIVE 5
320 SYSTEMIC CANDIDA 5
321 THERAPEUTIC RESPONSE DECREASED 5
322 UNDERDOSE 5
323 UPPER RESPIRATORY TRACT INFECTION 5
324 UROSEPSIS 5
325 VITREOUS DEGENERATION 5
326 VITREOUS HAZE 5
327 ABSCESS 4
328 BACTERIAL TRANSLOCATION 4
329 BIOPSY KIDNEY ABNORMAL 4
330 BLOOD CREATININE ABNORMAL 4
331 BLOOD PRESSURE FLUCTUATION 4
332 C-REACTIVE PROTEIN INCREASED 4
333 CONJUNCTIVAL HYPERAEMIA 4
334 CYSTOID MACULAR OEDEMA 4
335 DERMATITIS CONTACT 4
336 DEVICE MALFUNCTION 4
337 DISTURBANCE IN ATTENTION 4
338 DRUG INTERACTION 4
339 DRUG LEVEL FLUCTUATING 4
340 DYSCHROMATOPSIA 4
341 ERECTILE DYSFUNCTION 4
342 ERYTHEMA OF EYELID 4
343 EXTRAVASATION 4
344 EYE PRURITUS 4
345 FEELING HOT 4
346 FLUID RETENTION 4
347 FULL BLOOD COUNT DECREASED 4
348 GINGIVAL BLEEDING 4
349 GLOMERULONEPHRITIS 4
350 GLOMERULOSCLEROSIS 4
351 GYNAECOMASTIA 4
352 HAEMORRHAGE SUBCUTANEOUS 4
353 HYPOKALAEMIA 4
354 HYPOMAGNESAEMIA 4
355 IMMUNOSUPPRESSION 4
356 INFLUENZA LIKE ILLNESS 4
357 INJECTION SITE DISCOLOURATION 4
358 INTENTIONAL PRODUCT MISUSE 4
359 IRIS HAEMORRHAGE 4
360 JOINT STIFFNESS 4
361 KERATIC PRECIPITATES 4
362 LETHARGY 4
363 MALIGNANT NEOPLASM PROGRESSION 4
364 NEPHROLITHIASIS 4
365 NEUROPATHY PERIPHERAL 4
366 NONINFECTIVE CHORIORETINITIS 4
367 OCULAR PROCEDURAL COMPLICATION 4
368 OPTICAL COHERENCE TOMOGRAPHY ABNORMAL 4
369 PANIC ATTACK 4
370 PHARYNGITIS 4
371 POSTERIOR CAPSULE OPACIFICATION 4
372 PRODUCT ADMINISTRATION INTERRUPTED 4
373 PRODUCT USE COMPLAINT 4
374 PULMONARY OEDEMA 4
375 PYELONEPHRITIS 4
376 RETINAL DEGENERATION 4
377 RETINAL EXUDATES 4
378 SCAR 4
379 SLEEP DISORDER 4
380 STRESS 4
381 TENSION HEADACHE 4
382 VASCULITIS 4
383 WRIST FRACTURE 4
384 ABORTION SPONTANEOUS 3
385 ACUTE PULMONARY OEDEMA 3
386 AGE-RELATED MACULAR DEGENERATION 3
387 AGITATION 3
388 ALANINE AMINOTRANSFERASE INCREASED 3
389 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 3
390 ANTERIOR CHAMBER FLARE 3
391 APHONIA 3
392 APHTHOUS ULCER 3
393 ARRHYTHMIA 3
394 ARTHROPOD BITE 3
395 BALANCE DISORDER 3
396 BLOOD ALBUMIN DECREASED 3
397 BLOOD CALCIUM INCREASED 3
398 BLOOD IRON INCREASED 3
399 BLOOD PRESSURE ABNORMAL 3
400 BLOOD UREA INCREASED 3
401 BONE MARROW DISORDER 3
402 BORDERLINE GLAUCOMA 3
403 BOWEN^S DISEASE 3
404 BRONCHITIS 3
405 BURNING SENSATION 3
406 CARDIAC FAILURE CONGESTIVE 3
407 CATHETER SITE PAIN 3
408 CHOLELITHIASIS 3
409 CHOLURIA 3
410 COLITIS 3
411 COMPLEMENT FACTOR C3 INCREASED 3
412 COMPLICATIONS OF BONE MARROW TRANSPLANT 3
413 CRYING 3
414 DELIRIUM 3
415 DEVICE DISLOCATION 3
416 DEVICE DISPENSING ERROR 3
417 DEVICE INFUSION ISSUE 3
418 DIPLOPIA 3
419 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 3
420 DRUG INTOLERANCE 3
421 DRY MOUTH 3
422 DYSPNOEA EXERTIONAL 3
423 EYE DISORDER 3
424 EYE EXCISION 3
425 EYE INFECTION STAPHYLOCOCCAL 3
426 EYE INJURY 3
427 EYELID PTOSIS 3
428 FEBRILE NEUTROPENIA 3
429 FEELING COLD 3
430 FLATULENCE 3
431 GAIT INABILITY 3
432 GASTROINTESTINAL DISORDER 3
433 GLYCOSYLATED HAEMOGLOBIN INCREASED 3
434 HAEMATOCHEZIA 3
435 HAEMATOMA 3
436 HALLUCINATION, VISUAL 3
437 HORDEOLUM 3
438 HOT FLUSH 3
439 HYPERGLYCAEMIA 3
440 HYPERSOMNIA 3
441 HYPONATRAEMIA 3
442 HYPOTHYROIDISM 3
443 IMMUNE-COMPLEX MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS 3
444 INCREASED APPETITE 3
445 INFUSION RELATED REACTION 3
446 INFUSION SITE HAEMORRHAGE 3
447 INFUSION SITE REACTION 3
448 INJECTION SITE RASH 3
449 INJECTION SITE SCAR 3
450 INJECTION SITE URTICARIA 3
451 INJURY 3
452 JOINT RANGE OF MOTION DECREASED 3
453 JOINT SWELLING 3
454 KERATORHEXIS 3
455 LABORATORY TEST INTERFERENCE 3
456 LACTIC ACIDOSIS 3
457 LEUKOCYTOSIS 3
458 LIMB INJURY 3
459 LIQUID PRODUCT PHYSICAL ISSUE 3
460 LIVER DISORDER 3
461 LUNG DISORDER 3
462 METABOLIC ACIDOSIS 3
463 MIDDLE INSOMNIA 3
464 MUSCULOSKELETAL DISORDER 3
465 MYELOFIBROSIS 3
466 MYOCARDIAL INFARCTION 3
467 NASAL CONGESTION 3
468 NASAL DRYNESS 3
469 NEPHROPATHY TOXIC 3
470 NEPHROTIC SYNDROME 3
471 NOROVIRUS INFECTION 3
472 OSTEOARTHRITIS 3
473 OSTEONECROSIS 3
474 OVARIAN CYST 3
475 PANCREATITIS 3
476 PANCREATITIS ACUTE 3
477 PLEURAL EFFUSION 3
478 POLYMYALGIA RHEUMATICA 3
479 POST PROCEDURAL INFECTION 3
480 PROCEDURAL PAIN 3
481 PRODUCT CONTAMINATION PHYSICAL 3
482 PRODUCT QUALITY ISSUE 3
483 PUNCTATE KERATITIS 3
484 RASH ERYTHEMATOUS 3
485 RED BLOOD CELL SEDIMENTATION RATE INCREASED 3
486 RENAL DISORDER 3
487 RENAL TUBULAR INJURY 3
488 RESPIRATORY DISORDER 3
489 RESPIRATORY TRACT INFECTION 3
490 RETINAL INFARCTION 3
491 RHEGMATOGENOUS RETINAL DETACHMENT 3
492 SEIZURE 3
493 SENSITIVE SKIN 3
494 SKIN IRRITATION 3
495 SKIN REACTION 3
496 SKIN STRIAE 3
497 SMALL INTESTINAL OBSTRUCTION 3
498 SNEEZING 3
499 SUBCUTANEOUS ABSCESS 3
500 SYRINGE ISSUE 3
501 THERAPEUTIC PRODUCT EFFECT DECREASED 3
502 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 3
503 THERAPY INTERRUPTED 3
504 TRANSPLANT REJECTION 3
505 URINE PROTEIN/CREATININE RATIO INCREASED 3
506 UTERINE HAEMORRHAGE 3
507 VERTIGO 3
508 VISUAL ACUITY REDUCED TRANSIENTLY 3
509 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 3
510 ABNORMAL LOSS OF WEIGHT 2
511 ABNORMAL SENSATION IN EYE 2
512 ACCIDENTAL EXPOSURE TO PRODUCT 2
513 ACID BASE BALANCE ABNORMAL 2
514 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 2
515 ACUTE MYOCARDIAL INFARCTION 2
516 ACUTE RESPIRATORY DISTRESS SYNDROME 2
517 ADMINISTRATION SITE PAIN 2
518 AGGRESSION 2
519 ALTERED STATE OF CONSCIOUSNESS 2
520 ALTERED VISUAL DEPTH PERCEPTION 2
521 ANKLE FRACTURE 2
522 ANTERIOR CHAMBER DISORDER 2
523 ANTERIOR SEGMENT ISCHAEMIA 2
524 APPLICATION SITE ERYTHEMA 2
525 APPLICATION SITE EXFOLIATION 2
526 ARCUS LIPOIDES 2
527 ASCITES 2
528 ASPARTATE AMINOTRANSFERASE INCREASED 2
529 ASTHENOPIA 2
530 ASTHMA 2
531 AUTOIMMUNE HAEMOLYTIC ANAEMIA 2
532 BACTERIAL INFECTION 2
533 BELL^S PALSY 2
534 BENIGN PROSTATIC HYPERPLASIA 2
535 BLEPHARITIS 2
536 BLOOD CORTICOTROPHIN INCREASED 2
537 BLOOD GLUCOSE FLUCTUATION 2
538 BLOOD POTASSIUM DECREASED 2
539 BLOOD PRESSURE SYSTOLIC INCREASED 2
540 BLOOD PRODUCT TRANSFUSION DEPENDENT 2
541 BLOOD URINE 2
542 BULLOUS KERATOPATHY 2
543 CAPILLARY LEAK SYNDROME 2
544 CARDIOVASCULAR DISORDER 2
545 CATARACT CORTICAL 2
546 CATHETER SITE SWELLING 2
547 CEREBRAL INFARCTION 2
548 CHORIORETINAL DISORDER 2
549 CLOSTRIDIUM TEST POSITIVE 2
550 COAGULOPATHY 2
551 COGNITIVE DISORDER 2
552 COMPLEMENT SPLIT PRODUCTS INCREASED 2
553 COMPLICATIONS OF TRANSPLANTED KIDNEY 2
554 CONCUSSION 2
555 CORTISOL DECREASED 2
556 CYSTITIS 2
557 CYTOMEGALOVIRUS CHORIORETINITIS 2
558 DECREASED ACTIVITY 2
559 DEEP VEIN THROMBOSIS 2
560 DEMENTIA 2
561 DEPRESSED MOOD 2
562 DEVICE ADHESION ISSUE 2
563 DISCOURAGEMENT 2
564 DRY THROAT 2
565 DYSPEPSIA 2
566 DYSURIA 2
567 EAR PAIN 2
568 EMOTIONAL DISTRESS 2
569 ENDOCRINE OPHTHALMOPATHY 2
570 ENERGY INCREASED 2
571 ENTEROCOCCAL INFECTION 2
572 EPISCLERITIS 2
573 EVANS SYNDROME 2
574 EYE DISCHARGE 2
575 EYE MOVEMENT DISORDER 2
576 EYE OEDEMA 2
577 FAECES DISCOLOURED 2
578 FEAR OF INJECTION 2
579 FEEDING DISORDER 2
580 FIBRIN D DIMER INCREASED 2
581 FLUSHING 2
582 FOREARM FRACTURE 2
583 FRACTURE 2
584 FREQUENT BOWEL MOVEMENTS 2
585 FRUSTRATION TOLERANCE DECREASED 2
586 GASTRIC DILATATION 2
587 GASTRIC ULCER 2
588 GASTRIC ULCER HAEMORRHAGE 2
589 GASTROINTESTINAL HAEMORRHAGE 2
590 GIANT CELL ARTERITIS 2
591 GLOMERULAR FILTRATION RATE DECREASED 2
592 GRAVES^ DISEASE 2
593 HAEMATOCRIT DECREASED 2
594 HAEMATOMA INFECTION 2
595 HAEMODYNAMIC INSTABILITY 2
596 HAEMOGLOBIN INCREASED 2
597 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 2
598 HAEMOPHILUS INFECTION 2
599 HAEMORRHOIDS 2
600 HAND FRACTURE 2
601 HEAD DISCOMFORT 2
602 HEART RATE DECREASED 2
603 HEMIPARESIS 2
604 HEPATOCELLULAR CARCINOMA 2
605 HEPATORENAL FAILURE 2
606 HERNIA 2
607 HOSPITALISATION 2
608 HYALOSIS ASTEROID 2
609 HYPERHIDROSIS 2
610 HYPERKALAEMIA 2
611 HYPERTHERMIA 2
612 HYPERTROPHIC CARDIOMYOPATHY 2
613 HYPERVOLAEMIA 2
614 HYPOACUSIS 2
615 HYPOGEUSIA 2
616 HYPOPHAGIA 2
617 HYPOPHOSPHATAEMIA 2
618 ILL-DEFINED DISORDER 2
619 IMMUNE SYSTEM DISORDER 2
620 IMMUNE THROMBOCYTOPENIA 2
621 INFUSION SITE CYST 2
622 INFUSION SITE DISCHARGE 2
623 INFUSION SITE EXTRAVASATION 2
624 INFUSION SITE HAEMATOMA 2
625 INFUSION SITE SCAR 2
626 INJECTION SITE ECZEMA 2
627 INJECTION SITE FOREIGN BODY SENSATION IN EYE 2
628 INJECTION SITE IRRITATION 2
629 INJECTION SITE PALLOR 2
630 INJECTION SITE PARAESTHESIA 2
631 INTERNAL HAEMORRHAGE 2
632 INTERSTITIAL LUNG DISEASE 2
633 IRIS ADHESIONS 2
634 IRON DEFICIENCY ANAEMIA 2
635 IRON OVERLOAD 2
636 JOINT NOISE 2
637 KIDNEY INFECTION 2
638 KIDNEY TRANSPLANT REJECTION 2
639 KLEBSIELLA URINARY TRACT INFECTION 2
640 LEUKAEMIA 2
641 LEUKOCYTURIA 2
642 LIGAMENT SPRAIN 2
643 LOCALISED INFECTION 2
644 LUMBAR VERTEBRAL FRACTURE 2
645 LUPUS NEPHRITIS 2
646 LYMPH NODE ABSCESS 2
647 LYMPHOCYTE COUNT DECREASED 2
648 MACULAR OPACITY 2
649 MACULAR THICKENING 2
650 MARROW HYPERPLASIA 2
651 MEGAKARYOCYTES DECREASED 2
652 MELAENA 2
653 MENINGOCOCCAL SEPSIS 2
654 MENSTRUAL DISORDER 2
655 MENSTRUATION IRREGULAR 2
656 MICTURITION URGENCY 2
657 MIGRAINE WITH AURA 2
658 MILIARIA 2
659 MUSCLE SPASMS 2
660 MUSCLE TIGHTNESS 2
661 MUSCULOSKELETAL CHEST PAIN 2
662 NAIL DEFORMATION 2
663 NECROTISING RETINITIS 2
664 NEURALGIA 2
665 NEUTROPHIL COUNT DECREASED 2
666 NIGHT SWEATS 2
667 NONSPECIFIC REACTION 2
668 OCULAR ISCHAEMIC SYNDROME 2
669 OPEN ANGLE GLAUCOMA 2
670 OPHTHALMIC HERPES ZOSTER 2
671 OPTIC ATROPHY 2
672 OPTIC DISC HAEMORRHAGE 2
673 OPTIC NERVE INFARCTION 2
674 OPTIC NEUROPATHY 2
675 ORAL PURPURA 2
676 OSTEOMYELITIS 2
677 OTITIS MEDIA 2
678 OVERDOSE 2
679 PERIORBITAL SWELLING 2
680 PHOTOSENSITIVITY REACTION 2
681 PLATELET COUNT ABNORMAL 2
682 PNEUMONIA BACTERIAL 2
683 PNEUMONIA KLEBSIELLA 2
684 PNEUMONITIS 2
685 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 2
686 PRESBYOPIA 2
687 PRESCRIBED OVERDOSE 2
688 PRIMARY BILIARY CHOLANGITIS 2
689 PRODUCT CLOSURE ISSUE 2
690 PRODUCT COLOUR ISSUE 2
691 PRODUCT PACKAGING QUANTITY ISSUE 2
692 PRODUCT PREPARATION ERROR 2
693 PRODUCT PREPARATION ISSUE 2
694 PRODUCT SUBSTITUTION ISSUE 2
695 PROSTATITIS 2
696 PTERYGIUM 2
697 RED BLOOD CELLS URINE POSITIVE 2
698 RENAL CORTICAL NECROSIS 2
699 RENAL HAEMORRHAGE 2
700 RESTLESSNESS 2
701 RETICULOCYTE COUNT DECREASED 2
702 RETINAL ARTERY THROMBOSIS 2
703 RETINAL DEPIGMENTATION 2
704 RETINAL FIBROSIS 2
705 RETINAL NEOVASCULARISATION 2
706 RETINITIS 2
707 RETINOPATHY HYPERTENSIVE 2
708 RIB FRACTURE 2
709 ROAD TRAFFIC ACCIDENT 2
710 SEASONAL ALLERGY 2
711 SERUM FERRITIN INCREASED 2
712 SKIN ULCER 2
713 SLUGGISHNESS 2
714 STOMATITIS 2
715 STREPTOCOCCAL INFECTION 2
716 STREPTOCOCCUS TEST POSITIVE 2
717 STRESS AT WORK 2
718 SUBDURAL HAEMORRHAGE 2
719 SUDDEN VISUAL LOSS 2
720 SUPERFICIAL VEIN THROMBOSIS 2
721 SYSTOLIC HYPERTENSION 2
722 TENDONITIS 2
723 THERAPEUTIC RESPONSE SHORTENED 2
724 THERAPEUTIC RESPONSE UNEXPECTED 2
725 THERAPY CHANGE 2
726 TOOTH ABSCESS 2
727 TOXICITY TO VARIOUS AGENTS 2
728 TRANSFUSION 2
729 TRANSIENT ISCHAEMIC ATTACK 2
730 UPPER LIMB FRACTURE 2
731 URETHRAL STENOSIS 2
732 URINARY CASTS 2
733 URINE OUTPUT DECREASED 2
734 VARICES OESOPHAGEAL 2
735 VEIN DISORDER 2
736 VENTRICULAR TACHYCARDIA 2
737 VITREOUS FIBRIN 2
738 WALKING AID USER 2
739 WHITE BLOOD CELL COUNT ABNORMAL 2
740 WHITE BLOOD CELL COUNT INCREASED 2
741 YELLOW SKIN 2
742 ABDOMINAL HERNIA 1
743 ABDOMINAL MASS 1
744 ABDOMINAL NEOPLASM 1
745 ABDOMINAL PAIN LOWER 1
746 ABDOMINAL RIGIDITY 1
747 ABDOMINAL WALL DISORDER 1
748 ABDOMINAL WALL WOUND 1
749 ABSCESS ORAL 1
750 ABSCESS SWEAT GLAND 1
751 ACARODERMATITIS 1
752 ACCIDENT 1
753 ACCIDENTAL UNDERDOSE 1
754 ACNE 1
755 ACTIVATED PARTIAL THROMBOPLASTIN TIME SHORTENED 1
756 ACUTE CARDIAC EVENT 1
757 ACUTE LEUKAEMIA 1
758 ADENOCARCINOMA 1
759 ADENOVIRUS INFECTION 1
760 ADMINISTRATION SITE BRUISE 1
761 ADMINISTRATION SITE DISCOMFORT 1
762 ADMINISTRATION SITE INFLAMMATION 1
763 ADMINISTRATION SITE NODULE 1
764 ADMINISTRATION SITE SWELLING 1
765 ADVERSE EVENT 1
766 ADVERSE REACTION 1
767 ALCOHOL WITHDRAWAL SYNDROME 1
768 ALLERGY TO ARTHROPOD BITE 1
769 AMBLYOPIA 1
770 ANAESTHESIA 1
771 ANAPHYLACTOID REACTION 1
772 ANGINA PECTORIS 1
773 ANGLE CLOSURE GLAUCOMA 1
774 ANIMAL BITE 1
775 ANTERIOR CHAMBER OPACITY 1
776 ANTERIOR CHAMBER PIGMENTATION 1
777 ANTI-HLA ANTIBODY TEST POSITIVE 1
778 ANTINUCLEAR ANTIBODY POSITIVE 1
779 AORTIC VALVE DISEASE 1
780 APHASIA 1
781 APNOEA 1
782 APPETITE DISORDER 1
783 APPLICATION SITE HAEMATOMA 1
784 APPLICATION SITE INFLAMMATION 1
785 APPLICATION SITE INJURY 1
786 APPLICATION SITE RASH 1
787 APPLICATION SITE SWELLING 1
788 AQUEOUS MISDIRECTION 1
789 ARTERIAL DISORDER 1
790 ARTERIOVENOUS FISTULA OCCLUSION 1
791 ARTHROPATHY 1
792 ASPERGILLUS INFECTION 1
793 ASPLENIA 1
794 ASYMPTOMATIC BACTERIURIA 1
795 ATTENTION DEFICIT HYPERACTIVITY DISORDER 1
796 AZOTAEMIA 1
797 BACK DISORDER 1
798 BACTERIAL SEPSIS 1
799 BARRETT^S OESOPHAGUS 1
800 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 1
801 BILE ACID MALABSORPTION 1
802 BILE DUCT STONE 1
803 BILIARY COLIC 1
804 BIPOLAR DISORDER 1
805 BK VIRUS INFECTION 1
806 BLADDER HYPERTROPHY 1
807 BLADDER INJURY 1
808 BLOOD ALKALINE PHOSPHATASE DECREASED 1
809 BLOOD BILIRUBIN ABNORMAL 1
810 BLOOD CHLORIDE INCREASED 1
811 BLOOD CREATINE PHOSPHOKINASE INCREASED 1
812 BLOOD CULTURE POSITIVE 1
813 BLOOD LACTATE DEHYDROGENASE 1
814 BLOOD PRESSURE DECREASED 1
815 BLOOD PRESSURE INADEQUATELY CONTROLLED 1
816 BLOOD PRESSURE SYSTOLIC DECREASED 1
817 BLOOD TESTOSTERONE DECREASED 1
818 BLOOD URIC ACID DECREASED 1
819 BODY FLUID ANALYSIS 1
820 BONE DENSITY DECREASED 1
821 BONE PAIN 1
822 BRADYPHRENIA 1
823 BRUXISM 1
824 BUDD-CHIARI SYNDROME 1
825 BUNDLE BRANCH BLOCK RIGHT 1
826 CALCULUS BLADDER 1
827 CAMPYLOBACTER GASTROENTERITIS 1
828 CARBON DIOXIDE INCREASED 1
829 CARDIAC ARREST 1
830 CARDIAC DYSFUNCTION 1
831 CARDIAC FAILURE CHRONIC 1
832 CARDIAC FLUTTER 1
833 CARDIAC VALVE DISEASE 1
834 CARDIOGENIC SHOCK 1
835 CARDIOMEGALY 1
836 CARDIOPULMONARY FAILURE 1
837 CAROTID ARTERIOSCLEROSIS 1
838 CATHETER SITE DISCHARGE 1
839 CATHETER SITE ERYTHEMA 1
840 CATHETER SITE HAEMORRHAGE 1
841 CATHETER SITE INFECTION 1
842 CELLULITIS ORBITAL 1
843 CENTRAL OBESITY 1
844 CENTRAL SEROUS CHORIORETINOPATHY 1
845 CEREBROSPINAL FLUID LEAKAGE 1
846 CERVIX CARCINOMA 1
847 CHARLES BONNET SYNDROME 1
848 CHOKING 1
849 CHOLECYSTITIS 1
850 CHOLECYSTITIS ACUTE 1
851 CHOLESTASIS 1
852 CHORIORETINAL SCAR 1
853 CHOROIDAL HAEMORRHAGE 1
854 CHRONIC MYELOMONOCYTIC LEUKAEMIA 1
855 CHRONIC TRAUMATIC ENCEPHALOPATHY 1
856 CILIARY ZONULAR DEHISCENCE 1
857 CIRCUMORAL SWELLING 1
858 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1
859 CLOSTRIDIUM DIFFICILE COLITIS 1
860 CLUSTER HEADACHE 1
861 COLITIS ULCERATIVE 1
862 COLON CANCER 1
863 COLOUR BLINDNESS 1
864 COMA 1
865 COMPLEMENT FACTOR INCREASED 1
866 CONJUNCTIVITIS VIRAL 1
867 CONVERSION DISORDER 1
868 CORNEAL DEGENERATION 1
869 CORNEAL DYSTROPHY 1
870 CORNEAL EPITHELIUM DEFECT 1
871 CORNEAL EROSION 1
872 CORNEAL OPACITY 1
873 CORONARY ARTERY DISEASE 1
874 CORONARY ARTERY RESTENOSIS 1
875 CRITICAL ILLNESS 1
876 CRYPTOSPORIDIOSIS INFECTION 1
877 CSF PROTEIN INCREASED 1
878 CSF SHUNT CONVERSION 1
879 CUTANEOUS VASCULITIS 1
880 CYST 1
881 CYTOKINE RELEASE SYNDROME 1
882 DECREASED GAIT VELOCITY 1
883 DEFAECATION URGENCY 1
884 DEMENTIA ALZHEIMER^S TYPE 1
885 DERMATITIS 1
886 DERMATITIS ACNEIFORM 1
887 DERMATOCHALASIS 1
888 DETACHMENT OF RETINAL PIGMENT EPITHELIUM 1
889 DEVICE BREAKAGE 1
890 DEVICE CONNECTION ISSUE 1
891 DEVICE DEPLOYMENT ISSUE 1
892 DEVICE DIFFICULT TO USE 1
893 DEVICE RELATED INFECTION 1
894 DEVICE USE ISSUE 1
895 DIABETES MELLITUS 1
896 DIALYSIS 1
897 DISCHARGE 1
898 DISCONTINUED PRODUCT ADMINISTERED 1
899 DISEASE COMPLICATION 1
900 DISEASE RECURRENCE 1
901 DISORIENTATION 1
902 DISSEMINATED GONOCOCCAL INFECTION 1
903 DISSEMINATED INTRAVASCULAR COAGULATION 1
904 DIVERTICULITIS 1
905 DRUG DELIVERY SYSTEM MALFUNCTION 1
906 DRUG DOSE OMISSION BY DEVICE 1
907 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1
908 DRUG ERUPTION 1
909 DRUG RESISTANCE 1
910 DRUG SPECIFIC ANTIBODY 1
911 DRUG SPECIFIC ANTIBODY PRESENT 1
912 DYSAESTHESIA 1
913 DYSARTHRIA 1
914 DYSGEUSIA 1
915 DYSKINESIA 1
916 DYSPLASIA 1
917 EAR INFECTION 1
918 EAR PRURITUS 1
919 ECTROPION 1
920 ECZEMA 1
921 EMBOLIC STROKE 1
922 ENCEPHALITIS 1
923 ENDOCARDITIS 1
924 ENDOCARDITIS NONINFECTIVE 1
925 ENTEROBACTER BACTERAEMIA 1
926 EOSINOPHIL COUNT DECREASED 1
927 EOSINOPHILIA 1
928 EOSINOPHILIC PNEUMONIA 1
929 EPSTEIN BARR VIRUS POSITIVE MUCOCUTANEOUS ULCER 1
930 EPSTEIN-BARR VIRUS INFECTION 1
931 ERUCTATION 1
932 ERYSIPELAS 1
933 EUSTACHIAN TUBE DYSFUNCTION 1
934 EXERCISE TOLERANCE DECREASED 1
935 EXPOSURE TO EXTREME TEMPERATURE 1
936 EXUDATIVE RETINOPATHY 1
937 EYE INFARCTION 1
938 EYE OPACITY 1
939 EYELID FUNCTION DISORDER 1
940 EYELID INFECTION 1
941 EYELID MARGIN CRUSTING 1
942 EYELID PAIN 1
943 FABRY^S DISEASE 1
944 FACE OEDEMA 1
945 FACIAL PAIN 1
946 FACIAL PARALYSIS 1
947 FAECALOMA 1
948 FAECES SOFT 1
949 FEAR OF EATING 1
950 FEELING DRUNK 1
951 FEELING OF BODY TEMPERATURE CHANGE 1
952 FIBROMYALGIA 1
953 FINE MOTOR SKILL DYSFUNCTION 1
954 FOETAL DISTRESS SYNDROME 1
955 FOETAL EXPOSURE DURING PREGNANCY 1
956 FOLLICULAR LYMPHOMA 1
957 FOLLICULITIS 1
958 FOOD AVERSION 1
959 FOOD POISONING 1
960 FRACTURE PAIN 1
961 FUNGAL SKIN INFECTION 1
962 GASTRIC HAEMORRHAGE 1
963 GASTRIC POLYPS 1
964 GASTRITIS EROSIVE 1
965 GASTROENTERITIS 1
966 GASTROINTESTINAL INFECTION 1
967 GASTROINTESTINAL NECROSIS 1
968 GASTROINTESTINAL PAIN 1
969 GASTROINTESTINAL SOUNDS ABNORMAL 1
970 GASTROINTESTINAL WALL THICKENING 1
971 GENE MUTATION IDENTIFICATION TEST POSITIVE 1
972 GENERALISED ANXIETY DISORDER 1
973 GENERALISED OEDEMA 1
974 GENITAL INFECTION FEMALE 1
975 GENITAL SWELLING 1
976 GIANT PAPILLARY CONJUNCTIVITIS 1
977 GINGIVITIS 1
978 GLOMERULAR FILTRATION RATE ABNORMAL 1
979 GLOMERULONEPHRITIS MEMBRANOPROLIFERATIVE 1
980 GLUCOSE URINE PRESENT 1
981 GOUT 1
982 GRAFT COMPLICATION 1
983 GROIN PAIN 1
984 HAEMANGIOMA RUPTURE 1
985 HAEMATEMESIS 1
986 HAEMATOLOGICAL MALIGNANCY 1
987 HAEMOCHROMATOSIS 1
988 HAEMOLYTIC ANAEMIA 1
989 HAEMORRHAGE INTRACRANIAL 1
990 HAEMORRHAGIC VASCULITIS 1
991 HALLUCINATION 1
992 HALO VISION 1
993 HAPTOGLOBIN ABNORMAL 1
994 HAPTOGLOBIN INCREASED 1
995 HEART RATE ABNORMAL 1
996 HEART RATE IRREGULAR 1
997 HEAT EXHAUSTION 1
998 HEPATIC CYTOLYSIS 1
999 HEPATIC FUNCTION ABNORMAL 1